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Volume 58, Number 4 Abstracts 1151comparable outcomes and limb salvage rates for most indications. Although
technical success is higher with open revascularization for patients present-
ing with failed bypass grafts, the amputation rates are comparable. Mortality
rates are signiﬁcantly higher at 30 days and 1 year in the OR group.Table. Patient characteristics, severity of ischemia, and indications for
intervention
Open surgical
group, No. (%)
Endovascular
group, No. (%) P value
Smoking
<.001No 151 (51.4) 37 (25.5)
Former 49 (16.7) 42 (29.0)
Current 94 (32.0 66 (45.5)
Comorbidities
Coronary artery disease 144 (48.8) 79 (55.2) .21
End-stage renal disease/dialysis 12 (4.1) 6 (4.2) .95
Congestive heart failure 57 (19.3) 28 (19.6) .95
Chronic obstructive pulmonary 86 (29.2) 33 (23.1) .18
disease
Atrial ﬁbrillation 114 (38.6) 32 (22.4) .001
Chronic renal insufﬁciency 39 (13.2) 31 (22.0) .02
Diabetes 91 (30.9) 57 (40.1) .06
Cause of ischemia
Cardiac embolism 85 (27.1) 14 (9.1) <.001
Native artery thrombosis 103 (32.8) 37 (24) .05
Failed stent 32 (10.1) 41 (26.6) <.001
Failed bypass 98 (31.0) 56 (36.4) .25
Thrombosed peripheral
aneurysm
18 (5.7) 6 (3.9) .41
Aortoiliac embolism 13 (4.1) 8 (5.2) .61
Distribution by severity
Rutherford I 4 (1.27) 15 (9.74)
Rutherford IIa 127 (40.19) 108 (70.13)
Rutherford IIb 132 (41.77) 31 (20.13)
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Objectives: Spinal cord injury is a major complication of thoracoab-
dominal aortic operations. We aimed to investigate neuroprotective role
of olmesartan administered to rats before ischemia against ischemia-reperfu-
sion (I-R) injury.
Methods: Twenty-four Wistar albino rats were randomly divided into
three groups (n ¼ 8 per group): group I (control group, the sham-operation
group), group II (the I-R group undergoing aortic occlusion without phar-
macologic treatment), and group III (olmesartan-treated group receiving 3
mg/kg/d olmesartan for 14 days before ischemia). Spinal cord ischemia was
induced by infrarenal aortic clamping for 45 minutes, followed by reperfu-
sion. Neurologic status was assessed by using modiﬁed Tarlov score preop-
eratively and at 48 hours postoperatively. Spinal cords were harvested for
histopathologic examination with hematoxylin-eosin staining and biochem-
ical analysis for tissue malondialdehyde, superoxide dismutase, and gluta-
thione peroxidase levels.
Results: The rats in the ischemia group had severe deﬁcits including
paraplegia after surgery, and they had a worse neurologic status compared
with the sham group (P < .05). The mean Tarlov scores in the ischemia
and olmesartan-treated groups at 48 hours postoperatively were 1.6 6
0.4 and 2.2 6 0.9, respectively (P < .05). Histopathologic analyses
demonstrated typical changes of ischemic necrosis in the ischemia group;
however, olmesartan attenuated tissue necrosis. Decreased spinal cord
tissue malondialdehyde (P ¼ .047) and increased tissue superoxide dismu-
tase (P ¼ .001) and glutathione peroxidase (P ¼ .009) levels were
measured in the olmesartan-treated group compared with the ischemia
group.
Conclusions: Olmesartan may protect the spinal cord from I-R injury
and reduce the incidence of associated neurological dysfunction after
temporary aortic occlusion.Impact of Chronic Kidney Disease on the Effectiveness of Peripheral
Endovascular Interventions
Heather L. Gill, Jeffrey J. Siracuse, Peter H. Connolly, John K. Karwowski,
Harry L. Bush, Darren B. Schneider, Andrew J. Meltzer. Weill Cornell
Medical College, New York, NY
Objectives: Patients with severe chronic kidney disease (CKD) were
excluded from the Society for Vascular Surgery objective performance goals
(OPG) derivation cohort due to established poor surgical outcomes in this
group. We examine the impact of diminished creatinine clearance (CrCl) on
the long-term outcomes of peripheral endovascular interventions.
Methods: Retrospective review of prospectively collected institutional
outcomes data (2006-2012) included calculation of CrCl and stratiﬁcation
by CKD class. Outcomes among those with mild (class 1, 2) moderate (class
3), and severe (class 4, 5) CKD were compared using Society for Vascular
Surgery OPG outcome metrics. Multivariate models were developed to iden-
tify risk factors for poor outcome and speciﬁcally assess the impact of CKD.
Results: 454 patients underwent treatment of 523 limbs for claudica-
tion (56%), rest pain (12%), or tissue loss (32%). Over 77% of patients had
abnormally low CrCl, with moderate CKD noted in 37% and severe CKD in
13%. Increasing CKD class was associated with worse outcomes across all
outcome metrics by crude survival analysis. Following adjustment for all
other risk factors, the impact of severe CKD was independently associated
with reduced overall survival (HR, 2.69; 95% CI, 1.70-4.26; P < .001),
amputation-free survival (HR, 3.15; 95% CI, 2.04-3.86; P < .001), limb
salvage (HR, 4.35; 95% CI, 1.50-12.33; P ¼ .006), major adverse limb
events (HR, 2.07; 95% CI, 1.02-4.20; P ¼ .04), freedom from reinterven-
tion and amputation (HR, 1.82; 95% CI, 1.12-2.94; P ¼ .015), and
freedom from reintervention, amputation, and stenosis (HR, 1.58; 95%
CI, 1.02-2.46; P ¼ .041).
Conclusions: Moderate and severe CKD are highly prevalent among
patients with peripheral artery disease. While severe CKD adversely affects
long-term outcomes after ET as well as surgical bypass, quantiﬁcation of
the impact of reduced CrCl on survival- and limb-based metrics may
enhance risk adjustment for comparative effectiveness research and improve
patient-centered clinical decision-making.
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Objectives: Inpatient hospital length of stay (LOS) is a metric that is
increasingly associated with healthcare efﬁciency and quality. Infrainguinal
bypass has traditionally been associated with a long postoperative LOS.
We sought to identify preoperative risk factors for protracted postoperative
LOS after lower extremity bypass for critical limb ischemia (CLI) to better
anticipate those at risk while in the preoperative phase.
Methods: Patient data from the 2007-2009 American College of
Surgeons National Surgical Quality Improvement Program were used to
develop a speciﬁc database consisting of patients undergoing bypass surgery
for CLI (n ¼ 4894). Protracted postoperative LOS was deﬁned as the top
quartile of duration of hospitalization days from surgery until discharge.
Over 50 preoperative, procedural, and postoperative variables were tested
for association. Risk factors with signiﬁcant association (Pearson c2, P <
.05) were used to develop a logistic regression model for protracted postop-
erative LOS.
Results: Average postoperative LOS was 7.5 days (median, 6 days).
The top quartile of postoperative LOS >8 days, was used to deﬁne pro-
tracted LOS. Independent risk factors for protracted postoperative LOS
included distal bypass target (OR, 1.6; 95% CI, 1.4-1.8), non-Caucasian
race (OR, 1.67; 95% CI, 1.4-1.9), obesity (OR, 1.3; 95% CI, 1.1-1.5),
partial functional dependence (OR, 2.0; 95% CI, 1.7-2.3), complete func-
tional dependence (OR, 2.8; 95% CI, 1.8-4.3), history of cardiac disease
(OR, 1.5; 95% CI, 1.1-2.0), history of peripheral vascular interventions
(OR, 1.3; 95% CI, 1.1-1.5), bleeding disorders (OR, 1.2; 95% CI, 1.03-
1.4), emergency operation (OR, 1.9; 95% CI, 1.4-2.7), age greater than
80 (OR, 1.45; 95% CI, 1.3-1.7), tissue loss (OR, 1.9; 95% CI, 1.6-2.3),
extended preoperative hospitalization (OR, 2.2; 95% CI, 1.8-2.6), and dial-
ysis dependence (OR, 1.6; 95% CI, 1.3-2.0).
Conclusions: LOS has received signiﬁcant attention in the context of
the current healthcare climate and the Affordable Care Act. Here, we iden-
tify risk factors for protracted postoperative LOS after surgical bypass for
CLI, a metric of speciﬁc importance to vascular surgeons. These ﬁndings
provide important evidence for the ongoing dialogue regarding efforts to
reduce LOS. Here, we can identify patients early in the preoperative period
that may be at risk for increased LOS allowing early multidisciplinary inter-
vention with other medical and social services.
